Cessation of Nucleos(t)ide Analogue Therapy in Non-Cirrhotic Hepatitis B Patients with Prior Severe Acute Exacerbation.

Chia-Yeh LaiSheng-Shun YangShou-Wu LeeHsin-Ju TsaiTeng-Yu Lee

Published in: Journal of clinical medicine (2021)

Even though it creates a greater chance of HBsAg seroclearance, NA therapy cessation may result in a high risk of severe CR in non-cirrhotic CHB patients with prior SAE.

Keyphrases

chronic obstructive pulmonary disease
hepatitis b virus
early onset
stem cells
intensive care unit
mesenchymal stem cells
cell therapy